The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
NYS Entity Status
NYS Filing Date
FEBRUARY 10, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - 1253 GENESIS FOOD, CORP.
AROUND THE WEB
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
- Restaurant Review: A New Kind of Sichuan Restaurant for New York
By PETE WELLS - Tuesday Aug 1, 2017
In downtown Flushing, Queens, Guan Fu Sichuan shows off the rich variety of flavors beyond the familiar blast of chiles.
- NY State Comptroller Helps Stakeholders Take Action on Climate and Food
By Marian Conway - Thursday Jul 13, 2017
The changing environment, specifically climate change, is becoming a major piece of the global economic puzzle. Decisions are now increasingly based not just on the bottom line, but on the Earth’s future.
- Near The East River, Plans Emerge For NY’s Next Life Science Center
By Ben Fidler - Monday Aug 21, 2017
At a time when biotech incubators and shared spaces are beginning to multiply in Manhattan, work on what could rank among the city’s largest biotech centers—if it can all come together—is just getting underway. According to Paul Wexler, a longtime healthcare-focused real estate broker, construction should begin next year on what is being called the […]
- Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists
By Corie Lok - Monday Aug 14, 2017
Startups play a critical role in the innovation economy that we chronicle at Xconomy—transforming new ideas that begin in a lab into the products and companies of tomorrow. No surprise, then, that the startup category in our first-ever Awards program was a particularly competitive one, loaded with private companies (no more than 5 years old) […]
- Novel leukemia treatment could be 1st US gene therapy
By Associated Press - Thursday Jul 13, 2017
A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn’t...